Summit Trail Advisors, LLC Ionis Pharmaceuticals Inc Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$40.53 - $50.7 $833,864 - $1.04 Million	-20,574 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$44.08 - $55.05 $22.2 Million - $27.7 Million	-502,534 Reduced 96.07%	20,574 $523,000
Q1 2018 May 21, 2018	BUY	$44.08 - $55.05 $22.3 Million - $27.9 Million	506,015 Added 2960.36%	523,108 $523,000
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $859,777 - $1.1 Million	17,093	17,093 $898,000

412

140M

829K

789K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.79B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.